Prestige Consumer Healthcare
PBH
#4019
Rank
A$4.14 B
Marketcap
A$86.16
Share price
-1.92%
Change (1 day)
-36.90%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$5.84

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.54. In 2024 the company made an earnings per share (EPS) of A$6.26 an increase over its 2023 EPS that were of A-$2.34.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$5.84-6.63%
2024A$6.26-367.08%
2023A-$2.34-138.33%
2022A$6.1111.7%
2021A$5.4713.6%
2020A$4.82-651.67%
2019A-$0.87-148.78%
2018A$1.79-83.29%
2017A$10.71437.23%
2016A$1.99-34.13%
2015A$3.0352.94%
2014A$1.98-8.11%
2013A$2.15
2011A$1.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$16.21 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$10.05 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.48 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.98-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.46-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.95 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$2.05-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.48-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$43.09-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.78-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel